Rhinovirus as a driver of airway T cell dynamics in children with treatment-refractory recurrent wheeze
Severe asthma in children is notoriously difficult to treat, and its immunopathogenesis is complex. In particular, the contribution of T cells and relationships to antiviral immunity remain enigmatic. Here, we coupled deep phenotyping with machine learning methods to elucidate the dynamics of T cells in the lower airways of children with treatment-refractory recurrent wheeze, and examine rhinovirus (RV) as a driver. Our strategy revealed a T cell landscape dominated by type 1 and type 17 CD8+ signatures. Interrogation of phenotypic relationships coupled with trajectory mapping identified T cell migratory and differentiation pathways spanning the blood and airways that culminated in tissue residency, and involved transitions between type 1 and type 17 tissue-resident types. These dynamics were reflected in cytokine polyfunctionality. Use of machine learning tools to cross-compare T cell populations that were enriched in the airways of RV-positive children with those induced in the blood following experimental RV challenge precisely pinpointed RV-responsive signatures that contributed to T cell migratory and differentiation pathways. Despite their rarity, these signatures were also detected in the airways of RV-negative children. Together, our results underscore the aberrant nature of type 1 immunity in the airways of children with recurrent wheeze, and implicate an important viral trigger as a driver.
Authors
- Lyndsey M. Muehling (ORCID: https://orcid.org/0000-0003-3203-3264)
- Kristin Wavell
- Judith A. Woodfolk (ORCID: https://orcid.org/0000-0002-8915-4334)
- W. Gerald Teague (ORCID: https://orcid.org/0000-0002-5596-606X)
- Naomi Bryant (ORCID: https://orcid.org/0000-0001-5807-9397)
Institutions
- University of Virginia (US)
Publication Details
- Journal
- JCI Insight
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1172/jci.insight.189480
- Citations
- 5
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 5.82
Funders
- NIH Office of the Director